Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.
Machover D, Diaz-Rubio E, de Gramont A, Schilf A, Gastiaburu JJ, Brienza S, Itzhaki M, Metzger G, N'Daw D, Vignoud J, Abad A, Francois E, Gamelin E, Marty M, Sastre J, Seitz JF, Ychou M. Machover D, et al. Ann Oncol. 1996 Jan;7(1):95-8. doi: 10.1093/oxfordjournals.annonc.a010489. Ann Oncol. 1996. PMID: 9081400 Free article. Clinical Trial.
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study.
Aranda E, Díaz-Rubio E, Cervantes A, Antón-Torres A, Carrato A, Massutí T, Tabernero JM, Sastre J, Trés A, Aparicio J, López-Vega JM, Barneto I, García-Conde J. Aranda E, et al. Ann Oncol. 1998 Jul;9(7):727-31. doi: 10.1023/a:1008282824860. Ann Oncol. 1998. PMID: 9739438 Free article. Clinical Trial.
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Díáz-Rubio E, Sastre J, Abad A, Navarro M, Aranda E, Carrato A, Gallén M, Marcuello E, Rifá J, Massuti T, Cervantes A, Antón A, Fernández Martos C. Díáz-Rubio E, et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):35-40. Oncology (Williston Park). 1999. PMID: 10442357 Free article. Clinical Trial.
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer.
Aranda E, Carrato A, Cervantes A, Sastre J, Gómez MA, Abad A, Masutti B, Ribera F, Marcuello E, Pronk L, Balcells M, Díaz-Rubio E; Grupo Español de Traitamiento de Tumores Digestivos. Aranda E, et al. Ann Oncol. 2004 Apr;15(4):559-67. doi: 10.1093/annonc/mdh158. Ann Oncol. 2004. PMID: 15033659 Free article. Clinical Trial.
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study.
Aranda E, Valladares M, Martinez-Villacampa M, Benavides M, Gomez A, Massutti B, Marcuello E, Constenla M, Cámara JC, Carrato A, Dueñas R, Reboredo M, Navarro M, Díaz-Rubio E. Aranda E, et al. Ann Oncol. 2009 Feb;20(2):251-7. doi: 10.1093/annonc/mdn557. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718892 Free article. Clinical Trial.
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).
Sastre J, Aranda E, Grávalos C, Massutí B, Varella-Garcia M, Rivera F, Soler G, Carrato A, Manzano JL, Díaz-Rubio E, Hidalgo M. Sastre J, et al. Crit Rev Oncol Hematol. 2011 Jan;77(1):78-84. doi: 10.1016/j.critrevonc.2009.11.005. Epub 2009 Dec 29. Crit Rev Oncol Hematol. 2011. PMID: 20042346 Clinical Trial.
325 results